ELIZABETH SCHEURER: Open Payments
NPI 1912285578 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 25 payments from 11 companies in 2025. Trend: 2023 $1,178 · 2024 $925 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $135 |
| Amgen Inc. | 4 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Novo Nordisk Inc | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| LeMaitre Vascular, Inc. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| United Therapeutics Corporation | 1 | $18 |
| BridgeBio Pharma, Inc. | 1 | $15 |
Products named: ELIQUIS, REPATHA, VYNDAQEL, JARDIANCE, WAINUA, HYDRO LEMAITRE VALVULOTOME, Kerendia, CAMZYOS.
Industry payments across ND — which companies pay providers there.
